The U.S. Food and Drug Administration (FDA) has taken a significant step forward in its post-market reassessment of phthalates used in food contact materials, signaling heightened regulatory scrutiny over a class of chemicals that has long drawn public health concern. The agency announced that it is actively reviewing the safety of authorized phthalate uses in food packaging and processing equipment, with implications for manufacturers, importers, and brand owners across the North American supply chain.
This review, which builds on evolving toxicological data and shifting consumer expectations, reflects the FDA’s broader commitment to re-evaluating legacy food contact substance authorizations. Companies whose products or packaging rely on phthalate-containing materials should pay close attention to how the agency’s findings may reshape compliance requirements in the months ahead.
What the FDA Review Covers
The FDA’s post-market review of phthalates used in food contact materials focuses on ortho-phthalates, a subgroup of phthalate esters historically permitted for use in adhesives, polymers, coatings, and other materials that come into contact with food during manufacturing, packaging, or storage. These substances have functioned primarily as plasticizers, lending flexibility to plastics and other polymeric materials.
Rather than launching an entirely new regulatory proceeding, the FDA is exercising its existing authority under section 409 of the Federal Food, Drug, and Cosmetic Act to reassess whether current authorized uses remain safe in light of updated scientific evidence. The agency has indicated it is considering exposure data, toxicological research, and dietary intake modelling as part of its evaluation. This includes a review of both direct and indirect food additive regulations that permit specific phthalate compounds in food-contact applications.
Why the Review Is Happening Now
Several converging factors have prompted this reassessment. Growing bodies of peer-reviewed research have associated certain ortho-phthalates with endocrine disruption, reproductive toxicity, and developmental effects. While individual studies vary in scope and methodology, the cumulative weight of evidence has shifted significantly since many of these substances were originally authorized for food contact use decades ago.
Concurrently, consumer advocacy organizations and environmental health groups have petitioned the FDA to revoke authorizations for phthalates in food packaging. A notable 2016 petition from a coalition of public-interest groups requested that the agency ban all ortho-phthalates from food-contact uses. After protracted delays, the FDA’s current review represents a concrete response to these long-standing demands. International regulatory developments have added further impetus, as the European Union has already restricted several phthalates under its food contact materials framework, and other jurisdictions continue to tighten controls.
Scope and Affected Product Categories
The FDA’s review encompasses a range of food contact applications where phthalates have been authorized. Companies in the following sectors should assess their exposure to this regulatory action:
- Flexible plastic food packaging, including wraps, pouches, and liners
- Adhesives and coatings used in food packaging assembly
- Gaskets, seals, and tubing in food processing equipment
- Conveyor belts and other repeated-use food contact surfaces
- Printing inks and pigment carriers applied to food packaging
While not every phthalate compound faces equal scrutiny, the FDA has signalled a comprehensive approach that could result in the revocation or amendment of multiple existing authorizations. The agency has not yet published a definitive timeline for final determinations, but it has committed to transparency throughout the review process.
Implications for Existing Compliance Frameworks
For companies whose food-contact materials currently comply with FDA regulations that permit specific phthalate uses, this review introduces a degree of regulatory uncertainty. Existing authorizations remain valid unless and until the FDA formally revokes or amends them. However, the direction of the review suggests that companies relying on phthalate-containing formulations should begin evaluating alternatives proactively rather than waiting for a final determination.
Material suppliers and packaging converters may face the most immediate pressure, as brand owners and food manufacturers increasingly require supply chain documentation confirming the absence of substances under regulatory review. Additionally, companies exporting to jurisdictions that have already restricted phthalates, such as the EU, may find that early reformulation serves both domestic and international compliance objectives simultaneously.
What This Means for Your Business
The practical impact of the FDA’s review depends on how extensively a company’s food contact materials rely on phthalate-based formulations. At a minimum, affected businesses should conduct a thorough audit of their food contact material supply chain to identify any components containing authorized phthalate compounds. This includes not only primary packaging but also secondary and tertiary materials, processing aids, and equipment surfaces.
Companies should also engage their raw material suppliers to obtain current certificates of compliance and composition declarations. If phthalate-containing substances are identified, developing a reformulation roadmap now will position the business to respond quickly if the FDA moves to restrict or revoke specific authorizations. Firms that have already transitioned to phthalate-free materials in response to market trends or international requirements may find themselves at an advantage, though they should still verify that substitute materials meet all applicable FDA food contact regulations.
Quality Smart Solutions advises companies to treat this review as an early signal rather than a distant possibility. Firms that integrate post-market regulatory monitoring into their compliance strategies are better equipped to manage transitions without disrupting production schedules or market access.
Frequently Asked Questions
Does this FDA review mean phthalates are immediately banned from food contact materials?
No, the review does not constitute an immediate ban. The FDA’s post-market reassessment is an evaluative process under section 409 of the Federal Food, Drug, and Cosmetic Act. Existing authorizations for phthalates used in food contact materials remain in effect while the review is underway. However, depending on the agency’s findings, specific authorizations could be revoked or amended, so companies should monitor the FDA’s updates closely and begin contingency planning.
Which specific phthalate compounds are under FDA review?
The FDA has focused its review on ortho-phthalates, a subgroup of phthalate esters that includes compounds historically authorized as plasticizers in food packaging materials, adhesives, and coatings. The agency has not published a single exhaustive list of every compound under scrutiny, but the review broadly encompasses substances permitted under existing direct and indirect food additive regulations. Companies should cross-reference their material compositions against FDA regulations in 21 CFR Parts 175 through 178 to identify potential exposure.
How might this review affect companies that export food products to the EU or other markets?
Companies already complying with the EU’s more restrictive framework on phthalates in food contact materials may find that they are well-positioned to meet any new FDA requirements that result from this review. However, the regulatory standards are not identical across jurisdictions, and a substance restricted in the EU may still be authorized under current FDA rules, or vice versa. Businesses operating across multiple markets should conduct jurisdiction-specific assessments to ensure that reformulation efforts satisfy all applicable requirements rather than assuming that compliance in one market guarantees compliance in another.
Key Takeaways
- The FDA is conducting a post-market review of ortho-phthalates authorized for use in food contact materials, driven by updated toxicological evidence and public petitions.
- Current authorizations remain valid during the review, but the trajectory suggests possible restrictions or revocations for specific phthalate compounds.
- Affected product categories include flexible packaging, adhesives, coatings, processing equipment components, and printing inks used in food contact applications.
- Companies should audit their food contact material supply chains now to identify phthalate-containing substances and begin evaluating alternatives.
- International regulatory trends, particularly in the EU, reinforce the direction of this FDA action and may offer useful benchmarks for reformulation strategies.
Preparing for What Comes Next
The FDA’s decision to advance its review of phthalates used in food contact materials marks a meaningful shift in how the agency is approaching legacy food contact substance authorizations. For companies in the food manufacturing and packaging sectors, this development warrants attention and proactive preparation rather than a wait-and-see approach
Conducting supply chain audits, engaging with material suppliers, and developing reformulation contingency plans are all reasonable steps that can reduce exposure to regulatory disruption. If your products involve food contact materials, now is the time to assess where you stand. Explore our FDA Food Compliance services or contact us to speak with a regulatory specialist.
